Galapagos | GLPG - Des Atouts

Prix De L'Action
28.30
Variation Quotidienne
-0.18 -0.63%
Mensuellement
-2.41%
Annuel
19.21%
Q1 Prévisions
27.05




Des Atouts Changement Date
argenx SE USD 7.18B 973.07M 2025-06
AstraZeneca USD 114.07B 382M 2025-12
Biogen USD 29.44B 232M 2025-12
Genmab DKK 6.46B 122M 2025-06
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
GRIFOLS EUR 19.71B 141.77M 2025-12
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Merck EUR 51.53B 600M 2025-12
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Novartis USD 107.29B 2.89B 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 126.81B 2.99B 2025-12
UCB EUR 17.35B 1.72B 2024-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12